期刊文献+

LC-MS/MS法测定盐酸噻吩诺啡鼻腔喷雾剂的生物利用度 被引量:2

Study on bioavailability of thenorphine hydrochloride nasal spray in rat using liquid chromatography-mass/mass spectrometry
原文传递
导出
摘要 目的:建立大鼠血浆中盐酸噻吩诺啡的液质联用测定法(LC-MS/MS法),比较盐酸噻吩诺啡片剂和鼻腔喷雾剂的生物利用度。方法:血浆中加入内标丁丙诺啡后甲醇沉淀蛋白。流动相:乙腈-0.01%甲酸,梯度洗脱,流速为0.5 mL.min-1,柱后分流。色谱柱:Agilent-C18柱(150 mm×2.1 mm,5 mm)。离子化方式:电喷雾离子化。多反应监测(multiple reaction monitoring,MRM):定量离子对,噻吩诺啡m/z522.5→m/z97.1,内标丁丙诺啡为m/z468.5→m/z396.2。结果:盐酸噻吩诺啡鼻腔喷雾剂、片剂的绝对生物利用度分别(70.84±51.16)%和(1.22±0.16)%,鼻喷剂的生物利用度极明显高于片剂(>58倍),其血药峰浓度明显大于口服给药。结论:建立了简单快速、特异性强且灵敏度高的LC-MS/MS法,用于盐酸噻吩诺啡的体内定量分析。盐酸噻吩诺啡鼻喷剂显著提高了其在大鼠体内的生物利用度,为临床应用提供一种新的剂型选择。 Objective: To establish a liquid chromatography-mass/mass spectrometry(LC-MS/MS) method for the determination of thenorphine hydrochloride in rat plasma and to compare the bioavailability of thenorphine hydrochloride tablet(suspension) and thenorphine hydrochloride nasal spray.Methods: Buprenorphine was the internal standard.The blood samples were extracted by methanol.Separation was performed on an ODS-C18 column(150 mm×2.1 mm,5 μm,Agilent,USA) with a mobile phase consisting of acetonitrile-0.01% formic acid at flow rate of 0.5 mL·min^-1.Detection was performed by a mass/mass spectrometer in Multiple Reaction Monitoring mode via ESI interface.Sample was monitored with the protonated ion currents at m/z=522.5m/z=97.1 for thenorphine hydrochloride and m/z=468.5m/z=396.2 for buprenorphine.Results: The Absolute bioavailability of nasal spray was(70.84±51.16)%,while conventional tablet was(1.22±0.16)%.The relative bioavailability of nasal spray was as 58 times as that of conventional tablet.Conclusion: A simple,sensitive and selective method was developed to determine simultaneously the concentrations of thenorphine hydrochloride with different formulations in rat plasma by LC-MS/MS method.The thenorphine hydrochloride nasal spray was confirmed with a higher relative bioavailability than conventional tablet,which would be provided as a new choice for the clinical application.
出处 《中国新药杂志》 CAS CSCD 北大核心 2010年第16期1450-1454,共5页 Chinese Journal of New Drugs
关键词 盐酸噻吩诺啡 鼻腔喷雾剂 生物利用度 液质联用测定法 thenorphine hydrochloride nasal spray bioavailability liquid chromatography-mass/mass spectrometry(LC-MS/MS) method
  • 相关文献

参考文献5

二级参考文献23

  • 1王永安,周文霞,刘艳芹,郑建全,刘克良,阮金秀.盐酸苯环壬酯对最大电休克发作及戊四氮惊厥模型的抗惊作用[J].药学学报,2005,40(6):501-506. 被引量:3
  • 2刘传缋,恽榴红.中枢解胆碱能抗晕动病新药盐酸苯环壬酯(英文)[J].中国药理学与毒理学杂志,2005,19(4):311-320. 被引量:14
  • 3Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences P.L.A. China.New use of phencynonate hydrochloride:WO/2002/067933 [P]. 2002-06-09.
  • 4Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences P.L.A. China. Use of pheneynonate Hyddrochloride for treating or alleviating epilepsy: WO/2005/099697[P]. 2005,10-27.
  • 5Institute of Pharmacology and Toxicology, Academy of Military Medical Sciences P.L.A. China. The me, dical use of levo-phencynonate as neuroprotective agent:WO/2008/086678 [P]. 2008-07-24.
  • 6MICHAEL I U, REMIGIUS U A, NORBERT V, et al. Nasal mucoadhesive drug delivery:Back- ground, applications, trends and future perspectives[J]. Adv Drug Deliv Rev,2005(57): 1640-1665.
  • 7[1]Wu J,Wei W,Wang LY.A thermosensitive hydrogel based on quatemized chitosan and poly(ethylene glycol)for nasal drug delivery system.Biomateriais,2007,28(13):2220-2232.
  • 8[2]Wang J,Tabata Y.Moriraoto k.Aminated gelatin microspheras as a nasal delivery system for peptide drugs:evaluation of in vitro release and in vivo insulin absorption in rats.J Control Release,2006,113(1):31-37.
  • 9[6l Ilium L.Nasal drug delivery-possibilities,problems and solutions.J Control Release,2003,87(1/3):187-198.
  • 10[7]Iqbal M,Lin W,Jabbal Gill I,et al.Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus(RSV)induces protective CTL responses in BALB/c mice.Vaccine,2003,21(13/14):1478-1485.

共引文献16

同被引文献36

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部